Bivallent vaccine containing virus types 16 and 18 used for the prevention of cervical cancer and other precancerous lesions.
Primarily used in girls and young women and now a days used between the age of 9-45 years.
Three doses to be given, second dose after one-two months of the first dose and third dose after six month for the first dose.
